Assessing the Quality of Initial Consultations Regarding Adjuvant Colon Cancer Therapy
نویسندگان
چکیده
منابع مشابه
Adjuvant therapy for colon and rectal cancer.
Newly diagnosed colon or rectal cancer should be staged using the TNM (tumor, node and distant metastasis) nomenclature to determine prognostic factors. Based on this staging, it is possible to select patients in need of adjuvant therapy following surgery. In patients with stage III colon cancer, adjuvant chemotherapy with fluorouracil and levamisole has been shown to produce a 40 percent reduc...
متن کاملNew approaches to the adjuvant therapy of colon cancer.
Analysis of data from patients treated outside clinical trials suggests that adjuvant chemotherapy for stage II colon cancer provides less than a 3% absolute improvement in survival at 5 years. This is remarkably close to the small degree of benefit suggested by controlled studies. An overview of the data suggests that surgery alone cures approximately 75% of stage II patients. Between 20% and ...
متن کاملAdjuvant Systemic Therapy in Stage II and III Colon Cancer
The prognosis of colon cancer is primarily determined through staging of the disease. After curative surgery, clinically occult micrometastases are thought to be the major source of disease recurrence. The main aim of postoperative systemic treatment is to eradicate micrometastases, thereby improving outcomes with an increased cure rate. Adjuvant systemic chemotherapy is indicated for patients ...
متن کاملAdjuvant therapy in stage II colon cancer: current approaches.
The Oncologist 2005;10:325–331 www.TheOncologist.com Correspondence: Al Benson III, M.D., F.A.C.P., Northwestern University, Division of Hematology/Oncology, 676 North St. Clair, Suite 850, Chicago, Illinois 60611, USA. Telephone: 312-695-6180; Fax: 312-695-6189; e-mail: a-benson@north western.edu Received November 2, 2004; accepted for publication January 25, 2005. ©AlphaMed Press 10837159/200...
متن کاملAdjuvant therapy in colon cancer--what, when and how?
Bolus fluorouracil and leucovorin has been accepted as the standard adjuvant therapy in stage III colon cancer for many years. New drugs such as irinotecan, oxaliplatin and oral fluoropyrimidines have all completed phase III randomised evaluation in colon cancer. Several of these studies have been reported in the last 24 months. Oxaliplatin-based chemotherapy is now emerging as the new standard...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Colorectal Cancer
سال: 2010
ISSN: 1533-0028
DOI: 10.3816/ccc.2010.n.016